Cancer Monoclonal Antibody Market Overview
The global cancer monoclonal antibody market is experiencing substantial growth, driven by increasing incidences of cancer, advancements in monoclonal antibody (mAb) technology, and the rising demand for targeted therapies. In 2023, the market was valued at approximately USD 112 billion and is expected to reach around USD 211 billion by 2030,...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian